These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 35107451)

  • 1. Structural and energetic features of the dimerization of the main proteinase of SARS-CoV-2 using molecular dynamic simulations.
    Zhang Y; Zheng L; Yang Y; Qu Y; Li YQ; Zhao M; Mu Y; Li W
    Phys Chem Chem Phys; 2022 Feb; 24(7):4324-4333. PubMed ID: 35107451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.
    Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF
    Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300.
    Davis DA; Bulut H; Shrestha P; Yaparla A; Jaeger HK; Hattori SI; Wingfield PT; Mieyal JJ; Mitsuya H; Yarchoan R
    mBio; 2021 Aug; 12(4):e0209421. PubMed ID: 34399606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases.
    Tekpinar M; Yildirim A
    J Biomol Struct Dyn; 2022 Sep; 40(14):6243-6254. PubMed ID: 33525993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors.
    Silvestrini L; Belhaj N; Comez L; Gerelli Y; Lauria A; Libera V; Mariani P; Marzullo P; Ortore MG; Palumbo Piccionello A; Petrillo C; Savini L; Paciaroni A; Spinozzi F
    Sci Rep; 2021 Apr; 11(1):9283. PubMed ID: 33927258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pH on stability of dimer structure of the main protease of coronavirus-2.
    Boonamnaj P; Pandey RB; Sompornpisut P
    Biophys Chem; 2022 Aug; 287():106829. PubMed ID: 35635893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases.
    Arouche TDS; Martins AY; Ramalho TC; Júnior RNC; Costa FLP; Filho TSA; Neto AMJC
    J Nanosci Nanotechnol; 2021 Apr; 21(4):2075-2089. PubMed ID: 33500022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric Regulation of 3CL Protease of SARS-CoV-2 and SARS-CoV Observed in the Crystal Structure Ensemble.
    Kidera A; Moritsugu K; Ekimoto T; Ikeguchi M
    J Mol Biol; 2021 Dec; 433(24):167324. PubMed ID: 34717972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 M
    Lis K; Plewka J; Menezes F; Bielecka E; Chykunova Y; Pustelny K; Niebling S; Garcia AS; Garcia-Alai M; Popowicz GM; Czarna A; Kantyka T; Pyrc K
    Int J Biol Macromol; 2024 May; 267(Pt 1):131392. PubMed ID: 38582483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
    Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
    Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
    Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
    Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of saquinavir as a potent inhibitor of dimeric SARS-CoV2 main protease through MM/GBSA.
    Bello M; Martínez-Muñoz A; Balbuena-Rebolledo I
    J Mol Model; 2020 Nov; 26(12):340. PubMed ID: 33184722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioguided Isolation of Cyclopenin Analogues as Potential SARS-CoV-2 M
    Thissera B; Sayed AM; Hassan MHA; Abdelwahab SF; Amaeze N; Semler VT; Alenezi FN; Yaseen M; Alhadrami HA; Belbahri L; Rateb ME
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolactin A as a Novel Inhibitory Agent for SARS-CoV-2 M
    Bharadwaj KK; Sarkar T; Ghosh A; Baishya D; Rabha B; Panda MK; Nelson BR; John AB; Sheikh HI; Dash BP; Edinur HA; Pati S
    Appl Biochem Biotechnol; 2021 Oct; 193(10):3371-3394. PubMed ID: 34212286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations.
    Chen S; Chen L; Tan J; Chen J; Du L; Sun T; Shen J; Chen K; Jiang H; Shen X
    J Biol Chem; 2005 Jan; 280(1):164-73. PubMed ID: 15507456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism.
    Ho CY; Yu JX; Wang YC; Lin YC; Chiu YF; Gao JY; Lai SJ; Chen MJ; Huang WC; Tien N; Chen Y
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition mechanism and hot-spot prediction of nine potential drugs for SARS-CoV-2 M
    Luo S; Huang K; Zhao X; Cong Y; Zhang JZH; Duan L
    Nanoscale; 2021 May; 13(17):8313-8332. PubMed ID: 33900318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.